A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 1999
To make stavudine (d4T) available to patients with advanced HIV disease for whom no alternative antiretroviral is satisfactory. To study the safety and efficacy of two dose levels in a twice-daily regimen.
Epistemonikos ID: 9abe2402deea9b7b4c52ed9e457a5f0d0d3550d7
First added on: Dec 01, 2021